As the Senior Product Manager – HAE, reporting into Business Unit Director for the Hematology/HAE/Respiratory you will lead the development of the commercial launch plan for ANDEMBRY® the first approved factor XIIa inhibitor for the treatment of Hereditary Angioedema (HAE.)
You will oversee the needs and strategy for the other products within CSL Canada's HAE Franchise (Berinert and HAEGARDA.)
Collaborate with key opinion leaders and various stakeholders to commercialize ANDEMBRY in Canada while continuing to support Berinert and HAEGARDA through co-positioning.
Work with health-care professionals, patient groups, and payors to optimize the launch of ANDEMBRY.
You will promote and manage the core strategies, tactics, budget, and communication plan for the 3 brands within the HAE portfolio. Key to this role is leading the support team members in aligning to the strategic goals, executing plan, including engagement with local market access, medical affairs, operations (logistics) and our international above market team supporting affiliates like Canada.
Manage multiple initiatives simultaneously, requiring strategic thinking, leadership, collaboration, innovation, business analytics (including forecasting and market tracking.)
You will have responsibilities for leading annual brand planning, agency management and developing relationships with external stakeholders.
Have primary responsibility for the strategic and marketing planning process for the assigned brand. Develop the annual strategic and marketing plan based on market definition and segmentation.
Gain understanding of relevant customer needs, analyze market data, and identify critical market trends and opportunities. Oversee the launch of ANDEMBRY across Canada, ensuring it meets financial targets and market shares objectives.
Develop and execute brand growth strategies. Gain management approval by presenting detailed tactical plans before implementation of programs. Lead all aspects of tactical implementation, including timelines, creation of promotional materials, delivery of French version for all materials, and guiding training of internal stakeholders and field-based professionals if appropriate.
Assume overall brand budget accountability. Work with finance and Business Unit Director to monitor spending against budget/forecast.
Interact with key internal stakeholders to ensure strategies are linked to achievement of critical business objectives. Key internal stakeholders include Medical Affairs, R & D, Finance, International Marketing, Regulatory, Sales, Market access and Manufacturing. Ensures that field-based professionals are aligned with brand strategies.
Develop and manage effective agency relationships. Selects vendors for brand programs and projects. Builds effective working relationships with key external customers, including thought leaders and patient advocacy groups.
Participate upon request as an active member of the International Marketing Teams, which is functionally responsible for the overall management and direction of the products under the Senior Product Manager's ambit including new pipeline products. This also includes leveraging support for strategy, execution and insights from this team.
Develops relationships with key external customers (to include Health Care Providers, Channel Partners, and Patient Groups) to maintain a thorough understanding of current market conditions. Effectively manages changes in market conditions related to brand strategy and tactics while communicating potential market impact to Sr. Management.
Lead launch and implementation of new product life cycle developments for Canadian market, responsibilities include project management, collaboration, strategic alignment and tactical implementation.
Manage the internal legal, regulatory, and medical approval of new materials to deliver needed materials promptly compliantly.
Lead the franchise's strategy plan and ensure all 3 brands are co-positioned to address and defend against competitive threats.
Qualifications:
This is a hybrid role out of our Ottawa, Canada offices
CSL Behring has an agile workplace policy, which allows managers and their employees to choose an in-office and remote working arrangement that works best for delivery on goals if the minimum for in-office presence of 3 days per week is respected.
We encourage you to make your well-being a priority. It’s important and so are you. Learn more about how we care at CSL.
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future. Learn more Inclusion and Belonging | CSL